RBC Europe’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-478
Closed -$8.8K 1077
2021
Q3
$8.8K Hold
478
﹤0.01% 960
2021
Q2
$6.67K Hold
478
﹤0.01% 1016
2021
Q1
$7.04K Hold
478
﹤0.01% 960
2020
Q4
$9.27K Hold
478
﹤0.01% 890
2020
Q3
$5.33K Sell
478
-210
-31% -$2.34K ﹤0.01% 900
2020
Q2
$9.31K Hold
688
﹤0.01% 782
2020
Q1
$5.56K Buy
688
+90
+15% +$727 ﹤0.01% 819
2019
Q4
$5.75K Hold
598
﹤0.01% 894
2019
Q3
$6.34K Hold
598
﹤0.01% 866
2019
Q2
$6.88K Buy
598
+153
+34% +$1.76K ﹤0.01% 868
2019
Q1
$5.7K Hold
445
﹤0.01% 914
2018
Q4
$2.74K Hold
445
﹤0.01% 975
2018
Q3
$4.68K Buy
+445
New +$4.68K ﹤0.01% 970